Skip to main content
SpringerLink
Log in

Hypertensive Patients with Raynaud’s Phenomenon or Intermittent Claudication and Their Treatment with Ketanserin

  • Short Communication
  • Poster Presentations: Ketanserin in Essential Hypertension
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Kunnen JJ, Dahler HP, Doorenspleet JG, van Oene JC. Effects of intra-arterial ketanserin in Raynaud’s phenomenon assessed by 99mTc-pertechnetate scintigraphy. European Journal of Clinical Pharmacology 34: 267–271, 1988

    Article  CAS  PubMed  Google Scholar 

  • Lijnen P, Fagard R, Staessen J, Blaton V, Hollez P, et al. Serum cholesterol during ketanserin and propranolol administration in hypertensive patients. Journal of Cardiovascular Pharmacology 10: 647–650, 1987

    Article  CAS  PubMed  Google Scholar 

  • Roald OK, Seem E. Treatment of Raynaud’s phenomenon with ketanserin in patients with connective tissue disorders. British Medical Journal 285: 1069–1071, 1984

    Google Scholar 

  • Rosendorff C, Murray GD. Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: only ketanserin’s hypotensive effect is age-related. Journal of Hypertension 4(Suppl. 6): S109–S111, 1986

    Google Scholar 

  • Sheps SG, Schirger A, Zachariah PK, Fisher LD, Spiekerman RE, et al. Comparison of ketanserin and metoprolol in the treatment of essential hypertension. Archives of Internal Medicine 147: 291–296, 1987

    Article  CAS  PubMed  Google Scholar 

  • Thulesius O, Lundvall J, Kroese A, Stranden E, Hallböök T, et al. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications. Journal of Cardiovascular Pharmacology 9: 728–733, 1987

    Article  CAS  PubMed  Google Scholar 

  • Vanhoutte PM, Ball SG, Berdaux A, Cohen ML, Hedner T, et al. Mechanism of action of ketanserin in hypertension. Trends in Pharmacological Sciences 7: 58–59, 1986

    Article  CAS  Google Scholar 

  • Wenting GJ, Woittiez AJJ, Man in’t Veld AJ, Schalekamp MADH. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109, 1984

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Research, Janssen Pharmaceutica B.V., Postbus 90240, 5000 LT, Tilburg, The Netherlands

    J. C. van Oene

Authors
  1. J. C. van Oene
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Oene, J.C. Hypertensive Patients with Raynaud’s Phenomenon or Intermittent Claudication and Their Treatment with Ketanserin. Drugs 36 (Suppl 1), 148–151 (1988). https://doi.org/10.2165/00003495-198800361-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800361-00030

Keywords

Search

Navigation